Cisplatin-resistant cells in malignant pleural mesothelioma cell lines show ALDHhighCD44+ phenotype and sphere-forming capacity
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Cisplatin-resistant cells in malignant pleural mesothelioma cell lines show ALDHhighCD44+ phenotype and sphere-forming capacity ; volume:14 ; number:1 ; day:30 ; month:4 ; year:2014 ; pages:1-13 ; date:12.2014
BMC cancer ; 14, Heft 1 (30.4.2014), 1-13, 12.2014
- Urheber
-
Cortes-Dericks, Lourdes
- Beteiligte Personen und Organisationen
-
Froment, Laurène
Boesch, Ruben
Schmid, Ralph Alexander
Karoubi, Golnaz
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-14-304
- URN
-
urn:nbn:de:1111-2016030412590
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Cortes-Dericks, Lourdes
- Froment, Laurène
- Boesch, Ruben
- Schmid, Ralph Alexander
- Karoubi, Golnaz
- SpringerLink (Online service)
Ähnliche Objekte (12)
Proteasome stress sensitizes malignant pleural mesothelioma cells to bortezomib-induced apoptosis
CD44 and its ligand hyaluronan as potential biomarkers in malignant pleural mesothelioma: evidence and perspectives
CK2α, over-expressed in human malignant pleural mesothelioma, regulates the Hedgehog signaling pathway in mesothelioma cells
Differential regulation of the sphere formation and maintenance of cancer-initiating cells of malignant mesothelioma via CD44 and ALK4 signaling pathways
ADAM10 mediates malignant pleural mesothelioma invasiveness
Early detection of malignant pleural mesothelioma
KRAS signaling in malignant pleural mesothelioma
Characterization and drug sensitivity profiling of primary malignant mesothelioma cells from pleural effusions
Chemotherapy increases CDA expression and sensitizes malignant pleural mesothelioma cells to capecitabine treatment
Molecular biological analysis of malignant pleural mesothelioma
Treatment of malignant pleural mesothelioma by fibroblast activation protein-specific re-directed T cells
Agonist activation of estrogen receptor beta (ERβ) sensitizes malignant pleural mesothelioma cells to cisplatin cytotoxicity
Proteasome stress sensitizes malignant pleural mesothelioma cells to bortezomib-induced apoptosis
CD44 and its ligand hyaluronan as potential biomarkers in malignant pleural mesothelioma: evidence and perspectives
CK2α, over-expressed in human malignant pleural mesothelioma, regulates the Hedgehog signaling pathway in mesothelioma cells
Differential regulation of the sphere formation and maintenance of cancer-initiating cells of malignant mesothelioma via CD44 and ALK4 signaling pathways
ADAM10 mediates malignant pleural mesothelioma invasiveness
Early detection of malignant pleural mesothelioma
KRAS signaling in malignant pleural mesothelioma
Characterization and drug sensitivity profiling of primary malignant mesothelioma cells from pleural effusions
Chemotherapy increases CDA expression and sensitizes malignant pleural mesothelioma cells to capecitabine treatment
Molecular biological analysis of malignant pleural mesothelioma
Treatment of malignant pleural mesothelioma by fibroblast activation protein-specific re-directed T cells
Agonist activation of estrogen receptor beta (ERβ) sensitizes malignant pleural mesothelioma cells to cisplatin cytotoxicity
Proteasome stress sensitizes malignant pleural mesothelioma cells to bortezomib-induced apoptosis
CD44 and its ligand hyaluronan as potential biomarkers in malignant pleural mesothelioma: evidence and perspectives
CK2α, over-expressed in human malignant pleural mesothelioma, regulates the Hedgehog signaling pathway in mesothelioma cells
Differential regulation of the sphere formation and maintenance of cancer-initiating cells of malignant mesothelioma via CD44 and ALK4 signaling pathways
ADAM10 mediates malignant pleural mesothelioma invasiveness
Early detection of malignant pleural mesothelioma
KRAS signaling in malignant pleural mesothelioma
Characterization and drug sensitivity profiling of primary malignant mesothelioma cells from pleural effusions
Chemotherapy increases CDA expression and sensitizes malignant pleural mesothelioma cells to capecitabine treatment
Molecular biological analysis of malignant pleural mesothelioma
Treatment of malignant pleural mesothelioma by fibroblast activation protein-specific re-directed T cells